课题基金 / 基金详情

Analysis of the mechanism of invasive growth of human glioblastomas

Analysis of the mechanism of invasive growth of human glioblastomas
人胶质母细胞瘤侵袭性生长机制分析
批准号:
15390429
负责人:
ISHIUCHI Shogo
金额:
$8.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

ISHIUCHI Shogo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent studies show that Ca^<2+>-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors play an important role in the growth of glioblastomas. However, the signaling pathway controlling the proliferation of glioblastoma cells is poorly understood. Protein kinase B/Akt has a critical role in tumorigenesis and can enhance proliferation and inhibit apoptosis in cancer cells. Here we show that Ca^<2+>-signaling mediated by AMPA receptors regulates the motility and growth of glioma cells through the activation of Akt. Ca^<2+> supplied through the Ca^<2+>-permeable AMPA receptors phosphorylated Akt at Ser 473, thereby facilitating proliferation as well as mobility. A dominant negative form of Akt inhibits the proliferation and migration accelerated by overexpression of Ca^<2+>-permeable AMPA receptors. In contrast, introduction of a constitutively active form of Akt rescued tumor cells from apoptosis induced by their conversion to Ca^<2+>-impermeable receptors by adenovirus-mediated transfer of the GluR2 cDNA. Thus Akt functions as a downstream effector in Ca^<2+>-signaling by AMPA receptors and this pathway may be a novel target in the treatment of glioblastomas.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
神経膠芽腫に対する新たな分子標的療法・グルタミン酸受容体阻害剤
胶质母细胞瘤新分子靶向治疗/谷氨酸受体抑制剂
DOI: --
发表时间: 2003
期刊: NEUROLOGICAL SURGERY 脳神経外科 第31巻 第5号
影响因子: --
作者: [Kato, Y, Shiraishi T, 石内勝吾]
通讯作者: 石内勝吾
Oligodendroglial tumors and mixed gliomas の分子細胞生物学的特性
少突胶质细胞瘤和混合性胶质瘤的分子和细胞生物学特征
DOI: --
发表时间: 2004
期刊: Brain Tumor Pathology 21巻
影响因子: --
作者: [Imahori Y, et al., Hashizume K, 石内勝吾]
通讯作者: 石内勝吾
AMPA型・グルタミン酸受容体と神経膠芽腫の浸潤性増殖
AMPA型谷氨酸受体与胶质母细胞瘤的侵袭性生长
DOI: --
发表时间: 2003
期刊: CLINICAL NEUROSCIENCE Vol.21 No.7
影响因子: --
作者: [石内勝吾, 小澤瀞司]
通讯作者: 小澤瀞司
グリオーマとグルタミン酸受容体 特集「グルタミン酸受容体-分子機構から治療戦略へ」
胶质瘤与谷氨酸受体专题:“谷氨酸受体——从分子机制到治疗策略”
DOI: --
发表时间: 2006
期刊: Clinical Neuroscience 24巻2号(in press)
影响因子: --
作者: [Nagasaki K, Matsumoto K, Kaneda M, Shintani T, Shibutani S, Murayama T, Wakabayashi G, Shimazu M, Mukai M, Kitajima M., 石内勝吾]
通讯作者: 石内勝吾
16
    Increased motility of cancer cells through surface trafficking of GluR1 AMPA receptors by nitric oxide in response to ionizing radiation
    • 批准号:
      23390352
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.73万
    • 财政年份:
      2011
    • 负责人:
      ISHIUCHI Shogo
    • 依托单位:
    Analysis of the mechanism of invasive growth of human glioblastomas. PART II
    • 批准号:
      17390391
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.18万
    • 财政年份:
      2005
    • 负责人:
      ISHIUCHI Shogo
    • 依托单位:
    海外基金